GE Healthcare Gets Priority Review for Molecular Imaging Agent
Molecular Insight Pharmaceuticals, Inc. Reports Onalta(TM) Tissue Distribution Data Support Clinical Developme
Endocrinology, An Issue of PET Clinics
Molecular Insight Pharmaceuticals, Inc. Reports Preliminary Results Of Azedra' Phase I Trial In Neuroendocrine
Satratoxin G-Induced Apoptosis in PC-12 Neuronal Cells is Mediated by PKR and Caspase-Independent
Molecular Insight Pharmaceuticals, Inc. Reports Preliminary Results of Azedra(TM) Phase I Trial in Neuroendocr
Molecular Insight Pharmaceuticals, Inc. Reports Preliminary Results of Azedra(TM) Phase I Trial in Neuroendocr
Molecular Insight Initiates Phase 2a Azedra Clinical Trial
Study findings from University of Helsinki, Finland, enhance human health research
Molecular Insight Pharmaceuticals, Inc. Initiates Azedra Therapeutic Trial in Neuroendocrine Cancer Patients
Molecular Insight Pharmaceuticals, Inc. Announces First Quarter 2007 Financial Results
Molecular Insight Pharmaceuticals, Inc. Announces First Quarter 2007 Financial Results
Data on tissue engineering published by researchers at Tokyo University
Study results from Case Western Reserve University, Department of Nutrition broaden understanding of gene therapy
Recent findings in autoimmunity described by researchers from University of Manitoba, Department of Immunology
Scientists at Whitehead Institute for Biomedical Research publish research in neuroblastoma cell biology
Pain & Central Nervous System Week via NewsRx.com:
similar ...
Recent studies from University of Kentucky, U.S., add to knowledge base
Molecular Insight Pharmaceuticals, Inc. Acquires Clinical Stage, Targeted Radiotherapeutic Candidate Onalta(TM) (Formerly OctreoTher(TM))
Researchers from Institute of Pharmacology and Toxicology detail findings in cancer gene therapy
Research from Belgium, the United Kingdom and Australia add new data to neurology body of knowledge
